Pay in installments of $6.20 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
For Your Every Summer RSVP, with Code: SUMMER15
Description
FDA Approves Tirzepatide for Chronic Weight Management Pharmacy Times Compounded Tirzepatide Microdose Tirzepatide Oral Starts at $279 mo PlexusDx Simplified Semaglutide: Automate Patient Weight Loss Support 12 Week Compounded Tirzepatide Program Elevate Health and Wellness Best Ozempic Alternative: The Role of GLP 1 Agonists in Weight Management Issaquah Reporter
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.4 ★★★★★
Based on 24 reviews
Sort
Product Reviews
★★★★★ 4
Good compromise
Size: 25-Foot, Style: 90° Locking End
I decided to go with this much cheaper version of the same yet higher quality cord from camping world. I really like the 90 degree connectors as these cords are heavy and I did not like the added stress on the RV power connector of the straight connectors. Also did not like the way the straight connector sticks out on camping would’s version so if I accidentally bumped into the cord it could easily be broken. The clamp ring on this one has large lugs making it much easier to tighten onto the RV threads. I really struggled with the ones that don’t have the large lugs. The easy to grip handles are also nice to have when removing from power. My one complaint, the cable jacketing is of lesser quality. You can literally feel the individual conductors inside the jacketing when handling. This makes me feel like this cord will not have the sturdiness to last over time and an insulation failure could be a dangerous situation. If I could get the connectors of this cord with the cable quality of the camping world version, I would pay for the quality.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 9, 2023
★★★★★ 5
Exactly what was needed.
Size: 25-Foot, Style: 90° Locking End
I needed to replace the 50 amp power cord to my motor home and this works great.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 27, 2024
★★★★★ 5
Great generator cord
Size: 25-Foot, Style: 90° Locking End
I’ve had this cord for 5 years for use with my emergency generator, it doesn’t get used often, but when I’ve needed it it’s been flawless.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 7, 2024
★★★★★ 5
Nice item
Size: 25-Foot, Style: Standard End
Nice item.
Modifying to two male ends, to make use of a built-in surge protector.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 21, 2026
★★★★★ 5
Awesome buy
Size: 50-Foot, Style: Standard End
Love these, I have used them for 4 years in all weather situations and they are still working great.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 22, 2026
recommand products
The 2023 ASA position on GLP-1 receptor agonists has been overturned by three 2025 consensus statements. Continue the drug. Change the fast. ANZCA/ADS/GESA/NACOS, the Association of Anaesthetists/RCoA, and SPAQI/AACE now converge on
23.77
The 2023 ASA position on GLP-1 receptor agonists has been overturned by three 2025 consensus statements. Continue the drug. Change the fast. ANZCA/ADS/GESA/NACOS, the Association of Anaesthetists/RCoA, and SPAQI/AACE now converge on
21.27
GLP-1 Receptor Agonists Expand Beyond Diabetes Treatment | Andrew J. Sauer, MD posted on the topic
28.85
GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies
23.31
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STO
21.51